<DOC>
	<DOC>NCT00968305</DOC>
	<brief_summary>Asthma is a very common childhood chronic illness and is generally more severe in African Americans. The investigators attempted to determine whether a specific immune marker is associated with lung function and asthma severity.</brief_summary>
	<brief_title>Interleukin (IL)-13 as a Marker in Pediatrics Asthma</brief_title>
	<detailed_description>This study examined the relationship between Interleukin (IL)-13 from phytohemagglutinin-activated polymorphonuclear blood cells and asthma severity, lung function (measured as FEV1%), and total serum IgE levels in African American children with clinically diagnosed asthma</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>AfricanAmerican race, born in the U.S. Age 815 years Clinical diagnosis of asthma Subject is able to understand and follow verbal instructions in English Asthma exacerbation in the 4 weeks preceding the research visit Oral/IV steroid use in the 4 weeks preceding the research visit Upper or lower respiratory tract infection in the 4 weeks preceding the research visit Antibiotic use in the 4 weeks preceding the research visit Use of a shortacting bronchodilator during the 6 hours prior to spirometry (lung function testing) Use of a longacting bronchodilator during the 12 hours prior to spirometry (lung function testing)</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>African American children with stable asthma</keyword>
	<keyword>Asthma severity</keyword>
	<keyword>Interleukin 13 from PHA stimulated PBMC</keyword>
	<keyword>Lung function (FEV1%)</keyword>
	<keyword>Total serum IgE</keyword>
	<keyword>Pediatrics</keyword>
</DOC>